Journal of Breast Cancer

Size: px
Start display at page:

Download "Journal of Breast Cancer"

Transcription

1 Journal of Breast Cancer ORIGINAL ARTICLE J Breast Cancer 2012 December; 15(4): Multiple Margin Positivity of Frozen Section Is an Independent Risk Factor for Local Recurrence in Breast-Conserving Surgery Jeeyeon Lee, Seokwon Lee, Youngtae Bae Department of Surgery, Pusan National University Hospital, Busan, Korea Purpose: Breast-conserving surgery (BCS) with radiotherapy has become a standard treatment for early stage breast cancer, since the installation of NSABP B-06. One of the serious problems in BCS is that of local recurrence. There are many risk factors for local recurrence, such as large tumor size, multiple tumors, axillary lymph node involvement, young age, high nuclear grade, and so on. The aim of this study is to identify patients with a higher risk of local recurrence of breast cancer. Methods: Between January 2002 and December 2006, 447 patients with breast cancer, and who had undergone BCS with immediate breast reconstruction, were enrolled in the study. The follow-up period was 5 years from the time of operation and we analyzed local recurrence, disease-free survival (DFS), and overall survival (OS). The analysis included various clinicopathological factors such as age, chemotherapy, radiotherapy, hormone therapy, pathologic characteristics, and margin status. Statistical analysis was performed with log-rank test and Kaplan-Meier method. The p-value <0.05 was considered statistically significant. Results: The mean follow-up period was 88 months and local recurrence of breast cancer occurred only in 16 cases (3.6%). The actual 5-year DFS, and OS rates were 90.6% and 93.3%, respectively. For the local recurrence of breast cancer, positive margin status, multiple margin positivity, conversed margin cases, T/N stages showed statistical significance in univariate analysis. However, only multiple margin positivity was identified as an independent risk factor for local recurrence in multivariate analysis. Conclusion: When the multiple margin positivity is diagnosed on intraoperative frozen biopsy, surgeons should consider a much wider excision of the breast and a more aggressive management. Key Words: Breast neoplasms, Local neoplasm recurrence, Segmental mastectomy INTRODUCTION Breast-conserving surgery with radiotherapy has become a standard treatment for early breast cancer since the treatment was determined to have an equivalent survival rate to mastectomy [1-4]. One of the serious problems in breast-conserving surgery is local recurrence and hence, the most important factor for successful breast-conserving surgery is the complete resection of the tumor. The local recurrence rate (LRR) of breast cancer has been reported as 3% to 20% [5-9]. Although several studies have Correspondence to: Youngtae Bae Department of Surgery, Pusan National University Hospital, 179 Gudeok-ro, Seo-gu, Busan , Korea Tel: , Fax: bytae@pusan.ac.kr This work was supported by clinical research grant from Pusan National University Hospital, Received: July 11, 2012 Accepted: November 28, 2012 reported that local recurrence does not greatly influence overall survival (OS), it still poses concerns since re-excision of the tumor is necessary and the incidence of contralateral breast cancer becomes much higher in cases with local recurrence [10]. The risk factors for local recurrence of breast cancer which have been reported include large tumor size [8,11], multifocality [9,12-16], axillary lymph node involvement [11], young age [9,17,18], high nuclear grade [12,19], extent of the intraductal component and positive surgical margin status. Among these, the most important factor involved in local recurrence is positive surgical margin status [7,9]. In order to perform a complete excision with clear resection margin, it is important to secure 1 to 2 cm of distance from tumor and perform an intraoperative evaluation of the margin status. When a positive surgical margin is reported on intraoperative frozen biopsy, or when a pathologic report for margin status shows a result to be reversed from negative to positive, re-excision should be performed to prevent local recurrence. These are very stressful situations for both patients and surgical oncologists. Thus, evaluation of the tumor size, number, location, and morph Korean Breast Cancer Society. All rights reserved. pissn This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( eissn licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

2 Multiple Margin Status in Breast-Conserving Surgery 421 ologic features should be done via imaging modalities prior to surgical planning. The aim of this study was to identify the most important high risk factors for local recurrence of breast cancer. The authors investigated additional risk factors besides those which have been previously suggested and focused on multiple surgical margin positivity. METHODS Between January 2002 and December 2006, the data of 447 patients with breast cancer who underwent breast-conserving surgery were collected for this study. Data were recorded prospectively and were analyzed retrospectively. Exclusion criteria included stage IV breast cancer, synchronous or metachronous malignancy in other organs. All breast cancer was diagnosed by needle or excision biopsy, and the size, number, and location of the tumor were identified through mammography, ultrasonography, and breast magnetic resonance imaging (MRI) prior to surgery. According to the tumor stage and characteristics, neoadjuvant chemotherapy, adjuvant chemotherapy, radiotherapy, or hormone therapy was applied in each case. Informed consent was obtained from all patients and the protocol used in this study was approved by the Institutional Review Board Committee of the Pusan National University Hospital (H ). Clinicopathological factors A follow-up period of 5 years was set up from the time of operation. Local recurrence, disease-free survival (DFS), and OS were investigated during this period. Disease follow-up was performed every 6 months based on blood tests with a tumor marker, chest plain X-ray, mammography, breast and abdomen ultrasonography, bone scan, brain computed tomography (CT), and positron emission tomography/computed tomography (PET/CT). The patients were divided into two age groups, based on 50 years as the supposed age of menopause. Patients were classified into groups that received neoadjuvant chemotherapy, adjuvant chemotherapy, radiotherapy or hormone therapy. Information from surgical margin status included simple positive results, multiple positive results and conversion cases which were negative in the frozen to positive in the final pathologic report. Surgical margin positivity was defined when the atypical cell, carcinoma in situ or invasive cancer cells existed within 5 mm of the cut surface. Multiple margin positivity was defined when margin positive results was found more than twice in the same site or in more than 2 different sites simultaneously (Figure 1). Basically, negative surgical margin is defined as the margin having at least 5 mm of free distance in the frozen section or in the final pathologic report. Conversion cases which underwent re-operation were included in positive margin cases. The morphologic features of the tumor margin were classified as round, irregular, spiculated, or amorphous, according to the images on breast MRI. Tumor type, stage, nuclear grade, histologic grade, presence of estrogen receptor or progesterone receptor, HER2/neu gene expression and triple negative were also verified from pathologic reports. Surgical technique with assessment of margin status The surgical margin is deemed to be 2 cm from the tumor by preoperative ultrasonography. When the tumor is not palpable, we performed ultrasound-guided H-wire localization not to miss the tumor during operation. Either sentinel node biopsy or axillary lymph node dissection was performed according to the axillary lymph node status. To evaluate the surgical margin A B C Figure 1. Definitions of surgical margin status. (A) Negative surgical margin means that the tumor is removed with more than 5 mm of free distances from resection margin. (B) Positive surgical margin (black arrow) is defined as when tumor cells are found on the resection margin. (C) Multiple positive surgical margin (black arrows) is defined as when tumor cells are found on more than two points of the resection margins.

3 422 Jeeyeon Lee, et al. status, tissues were obtained using the circumferential method from 12 directions of the surgical cavity. Determination of the surgical margin was performed by three different pathologists in random order. Re-excision and secondary margin evaluation were performed when margin positive was diagnosed in the intraoperative frozen section. After the negative results of surgical margin were confirmed, breast reconstruction methods such as local flap, thoraco-epigastric flap, lateral thoracic fasciocutaneous flap, and latissimus dorsi myocutaneous flap were applied according to the volume and location of removed breast tissue. Statistical analysis Statistical analyses were performed with SPSS version 16.0 (SPSS Inc., Chicago, USA). Categorical variables were compared using chi-square test and actual 5-year DFS, and OS was evaluated with the Kaplan-Meier method. Comparison of local recurrence-free survival between 2 groups was examined using the log-rank test in univariate analysis. A Cox proportional hazard model was used to analyze various prognostic factors in multivariate analysis. The p-value < 0.05 was considered statistically significant. RESULTS The mean age of the patients was 46.6 years (range, years) and the mean follow-up period was 88 months. In our study, local recurrence of breast cancer occurred only in 16 cases (3.6%) and actual 5-year DFS, and OS rates were 90.6% and 93.3%, respectively (Figure 2). Three hundred four patients (68.0%) were below the age of 50 years, and those under 50 years of age presented with a higher LRR than those over 50 years of age. There was, however, no statistical significance in the LRRs between the two age groups. Neoadjuvant chemotherapy and adjuvant chemotherapy were applied to 282 patients (63.1%) and 406 patients (90.8%), respectively. Moreover, irradiation was applied to nearly all patients (434, 97.1%) after breast-conserving surgery. The local recurrence of breast cancer was identified only in the group who received radiotherapy, and eight cases of local recurrence occurred equally in both groups treated with hormone therapy. These treatment modalities, however, were not statistically significant (Table 1). Table 1. Patient and treatment characteristics of breast-conserving surgery Characteristic No. of cases (%) Local recurrence p-value Age (yr)* 46.6± < (68.0) 11 (3.6) (32.0) 5 (3.5) Neoadjuvant chemotherapy Yes 282 (63.1) 11 (3.9) No 165 (36.9) 5 (3.0) Adjuvant chemotherapy Yes 388 (86.8) 15 (3.9) No 59 (13.2) 1 (1.7) Radiotherapy Yes 434 (97.1) 16 (3.7) No 13 (2.9) 0 ( Hormone therapy Yes 310 (69.4) 8 (2.6) No 137 (30.6) 8 (5.8) *Mean±SD Disease-free survival (%) Overall survival (%) Follow-up period (mo) A Follow-up period (mo) B Figure 2. Disease-free survival (90.6%) (A) and overall survival rates (93.3%) (B) after breast-conserving surgery.

4 Multiple Margin Status in Breast-Conserving Surgery 423 The mean tumor size was 2.0 cm and morphological features of the tumor margin were not associated with the local recurrence of breast cancer. However, overall, T and N stages of significantly contributed to the LRR of breast cancer (p< 0.001, p= 0.001, and p= 0.008, respectively). The tumor types were classified as ductal, lobular, mucinous lesion, and others. There were 52 cases (11.6%) of carcinoma in situ and 366 (81.8%) cases of invasive carcinoma lesions. We found no influence of tumor type on the risk of local recurrence. No differences were found in nuclear grade, histologic grade, lymphovascular invasion, and perineural invasion among the groups. Information of hormone receptors was available in 444 cases (99.3%), but again, no significant differences were found with regard to recurrence. In our study, HER2/neu gene positive rate, and triple negative rate were 25.3% and 14.8%, respectively and this was similar to other previous studies. However, unlike previous reports, HER2/neu positivity or triple negativity did not show a statistically significant association with LRR. Among 90 cases (20.1%) of positive surgical margin, multiple margin positivity was identified in 37 cases (8.3%). In 10 cases, the final pathologic report was conversed to frozen biopsy results from less to more aggressive lesion. Re-excision was performed in 4 cases and the other 6 cases received only irradiation. There were 10 (11.1%) and 9 (24.3%) cases of local recurrence in margin positive cases and multiple margin positive cases, respectively. Pathologically, LRR after the breastconserving surgery was attributable to a positive surgical margin, multiple margin positivity and conversion results (p< 0.001, p< 0.001, and p= 0.008, respectively). However, the types of positive margin and multiple margin positivity were not associated with local recurrence (p= 0.699, p= 0.424) (Table 2). Among various clinicopathological factors, the margin positive cases and multiple margin positive cases showed statistical significance only with T stage (p= 0.019, p= 0.011), and the pathologic characteristics of positive margin cases are shown in Table 3. The adjusted multivariate analysis for risk factor of local recurrence included a positive surgical margin, multiple margin positivity, conversion cases, T stage, N stage and overall stage which showed significance in univariate analysis. However, only multiple margin positivity was an independent risk factor for local recurrence of breast cancer (p= 0.031) (Table 4). In univariate analysis of OS, statistical significance was shown in N stage (p= 0.007), overall stage (p< 0.001), lymphovascular invasion (p=0.001), and presence of progesterone receptor (p = 0.021). However, only N stage and overall stage were associated with OS independently, and the local recurrence was not associated with OS in our study. Table 2. Disease characteristics of breast-conserving surgery Characteristic No. of cases (%) Local recurrence p-value Morphologic feature of tumor margin Round 143 (32.0) 7 (4.9) Irregular or spiculated 252 (56.4) 5 (2.0) Amorphous 52 (11.6) 4 (7.7) Overall stage < (11.6) 3 (5.8) I 265 (59.3) 8 (3.0) IIA 119 (26.6) 1 (0.8) IIB 11 (2.5) 4 (36.4) T stage Tis 52 (11.6) 3 (5.8) T1 286 (63.7) 9 (3.1) T2 101 (22.6) 2 (2.0) T3 8 (1.8) 2 (25.0) N stage N0 318 (71.1) 11 (3.5) N1 78 (17.4) 3 (3.8) N2 37 (8.3) 0 ( N3 14 (3.1) 2 (14.3) Tumor type Ductal carcinoma 407 (91.1) 13 (3.2) Lobular carcinoma 11 (2.5) 1 (9.1) Mucinous carcinoma 12 (2.7) 1 (8.3) Etc. 17 (3.8) 1 (5.9) Nuclear grade Grade 1 27 (6.0) 2 (7.4) Grade (59.1) 5 (1.9) Grade (34.9) 9 (5.8) Histologic grade Grade 1 53 (11.9) 4 (7.5) Grade (53.7) 4 (1.7) Grade (34.5) 8 (5.2) Lymphovascular invasion Yes 126 (28.2) 8 (6.3) No 321 (71.8) 8 (2.5) Perineural invasion Yes 11 (2.5) 4 (36.4) No 436 (97.5) 12 (2.8) Estrogen receptor Positive 242 (54.1) 8 (3.3) Negative 202 (45.2) 8 (4.0) Progesterone receptor Positive 268 (59.9) 8 (3.0) Negative 176 (39.4) 8 (4.5) HER2/neu gene < (74.7) 10 (3.0) (25.3) 6 (5.3) Triple negative Yes 66 (14.8) 2 (3.0) No 381 (85.2) 14 (3.7) Margin positive < Yes 90 (20.1) 10 (11.1) No 357 (79.9) 6 (1.7) Multiple margin positive < Yes 37 (8.3) 9 (24.3) No 410 (97.7) 7 (1.7) Conversion Yes 6 (1.3) 1 (16.7) No 441 (98.7) 15 (3.4)

5 424 Jeeyeon Lee, et al. Table 3. Pathologic characteristics of positive margin cases Characteristic Positive surgical margin DISCUSSION Multiple margin positivity No. of cases 90 (20.1) 37 (8.3) Types of resection margin Atypia 36 (8.1) 11 (2.5) Carcinoma in situ 45 (10.1) 22 (4.9) Invasive carcinoma 9 (2.0) 4 (0.9) Overall stage 0 16 (17.8) 8 (21.6) I 33 (36.7) 11 (29.7) IIA 21 (23.3) 9 (24.3) IIB 20 (22.2) 2 (5.4) T stage Tis 16 (17.8) 8 (21.6) T1 41 (45.6) 15 (40.5) T2 30 (33.3) 11 (29.7) T3 3 (3.3) 3 (8.1) N stage N0 67 (74.4) 27 (73.0) N1 8 (8.9) 3 (8.1) N2 9 (10.0) 3 (8.1) N3 6 (6.7) 4 (10.8) Estrogen receptor Positive 49 (54.4) 21 (56.8) Negative 41 (45.6) 16 (43.2) Progesterone receptor Positive 54 (60.0) 22 (59.5) Negative 36 (40.0) 15 (40.5) HER2/neu gene <3+ 26 (28.9) 28 (75.7) 2+ vs (71.1) 9 (24.3) Triple negative Yes 9 (10.0) 4 (10.8) No 81 (90.0) 33 (89.2) LRRs after breast-conserving surgery for breast cancer ranged from 2% to 20% and for early breast cancer were 12% and 20% at 5 and 10 years, respectively [5-9,20,21]. Although previous randomized trials have reported that groups with a high incidence of local recurrence demonstrate the same OS those with a low incidence of local recurrence [1,2], patients with local recurrence of breast cancer experience not only anxiety in relation to the recurrence, but stressful situations such as re-operation, and chemotherapy, etc. Hence, identification of patients with high risk factor of local recurrence is very important. The risk factors of local recurrence in breast cancer have been reported as young age, large tumor, positive surgical margin, extensive intraductal component, multifocality, axillary lymph node involvement, extranodal extension, and high nuclear grade. Among these factors, positive surgical margin is the Table 4. Results of the Cox proportional hazard analysis on risk factors for local recurrence Variate HR 95% CI p-value Positive surgical margin Multiple margin positivity Conversion cases T stage (vs. Tis) T < T < T N stage (vs. N0) N N < N < Overall stage (vs. stage 0) I < IIA < IIB < All data were adjusted by positive surgical margin, multiple margin positivity, conversion cases, T stage, N stage, and overall stage. HR=hazard ratio; CI=confidence interval. most important factor because it is the only factor which can be controlled by surgeons [6]. Generally, breast cancer in young age groups shows more aggressive tumor progression. However, there are some conflicting reports about the incidence of local recurrence between age groups [12,13,17]. In the present study, no difference in local recurrence was found between patients younger than 50 and those older than 50. However, it is difficult to draw conclusions since treatment strategies were not strictly controlled. Chemotherapy and radiotherapy have been reported to be associated with local control and OS. However, in our study, there was no significant association of the incidence of local recurrence with chemotherapy and radiotherapy. Nevertheless, the result is not reliable because most patients in this study received these treatments. Several studies reported the margin positive rate in primary excision from 4% to 14% [5,7,9]. When positive surgical margin is diagnosed, surgeons should perform re-excision immediately until the negative result is confirmed. Authors assessed the tumor size and location with preoperative imaging modalities and evaluated the frozen sections for surgical margins. In our study, primary margin positive rate and multiple margin positive rate were 20.1% and 8.3%, respectively. They showed statistical significance with local recurrence of breast cancer in univariate analysis. However, the multiple margin positivity was associated only with pathological T stage, and not with the clinical T stage. The multiple margin positivity was the only independent risk factor of local recurrence in adjusted multivariate analysis. This means that the rate of multiple margin positivity would be more detected in cases of larger pathologic

6 Multiple Margin Status in Breast-Conserving Surgery 425 tumors, and that the risk of local recurrence would be higher with inadequate resection, even if surgeons confirmed the negative surgical margin during operation and performed the standard treatments. In these cases, surgeons should consider a much larger scale of surgery or mastectomy to prevent the local recurrence of breast cancer to remove the still remained tumor cells. Of course, for successful results, surgeons and patients should discuss their options before surgery, and the surgeon should ideally be proficient in various oncoplastic techniques. According to previous reports, multiple margin positivity has been considered as an extensive ductal carcinoma in situ. However, positive results in our study included cases of atypical cells, carcinoma in situ, and invasive carcinoma. Ductal carcinoma in situ showed no significance in our study, in terms of its relationship with either the type of cancer or the stage of cancer. The surgical margin status has been accepted to be the most important risk factor, because it is the only risk factor which is controllable by surgeons. For the accurate diagnosis of surgical margin, there are several requirements. First, a guideline for the margin status should be established. There is no clear consensus as to the definition of a positive surgical margin. To establish a treatment guideline, an in-depth discussion between surgeons and pathologists, in order to achieve a definition of a positive result is needed. Based on previous reports, it might be reasonable for positive surgical margins to include atypical cells, in situ or invasive cancer cells within 5 mm from cut surface [22-24]. Second, adequate specimens should be obtained. There are some limitations to performing frozen biopsies when margin specimens contain an artifact of electrocautery or fat tissue. Margin tissue should be taken with surgical scissors from the breast parenchyma. Third, the surgical margin evaluation should be performed by surgeons. Only surgeons can recognize correct directions and decide for re-excision. Many authors are using total-circumference intraoperative frozen method and taking the tissues from the remnant breast cavity for margin evaluation, due to its varying directions and farther tissues from the tumor [25]. In pathologic assessments, conversion cases which were diagnosed as negative in the frozen, but as positive in the final pathologic report existed. When the surgical procedure is incomplete, re-excision is recommend for more than a focal degree of margin positivity and only irradiation treatment is enough for a focal degree of margin positivity [6]. There were 6 cases with irradiation treatment only in this study, and one case of local recurrence was confirmed during the follow-up. However, conversion case was not considered as an independent risk factor for local recurrence. Large tumor size, positive lymph nodes, estrogen-negative status, high histologic grade, and lymphovascular invasion are also risk factors for the local recurrence of breast cancer [7,26, 27]. Although, overall stage and T/N stages in this study showed statistical significance in univariate analysis, they were not independent factor, and other pathologic characteristics, including hormone status, were not associated with the local recurrence of breast cancer, even in univariate analysis. The most important point of this study is that multiple margin positivity would be an independent risk factor for the local recurrence of breast cancer, and the identification of tumor size and location, multifocality, and morphologic features of the tumor should be assessed before surgery in order to prevent multiple margin positive cases. However, only a few reports have described multiple margin positivity and they did not suggest guidelines for margin evaluation or treatment strategies. There are, of course, some limitations in our study. The follow-up period was only 5 years and this was a single institution investigation with a small population. According to the rules of thumb, such as 10 or more events per predictor variable, 16 cases of local recurrence in our study is not a sufficient number for a reliable prediction [28]. Hereafter, if a large population with long term follow-up in multicentric investigation is performed, a much more concrete conclusion will be drawn. Based on our results, multiple margin positivity of breast cancer is an independent risk factor for the local recurrence of breast cancer. In conclusion, authors recommend a much larger scale of oncoplastic surgery, equivalent to mastectomy, for successful breast-conserving surgery when multiple margin positivity is confirmed. ACKNOWLEDGEMENTS Authors thank to Jeeyeon Kim, pathologist, for her assistance and advice. CONFLICT OF INTEREST The authors declare that they have no competing interests. REFERENCES 1. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002;347: Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl

7 426 Jeeyeon Lee, et al. J Med 2002;347: Jacobson JA, Danforth DN, Cowan KH, d Angelo T, Steinberg SM, Pierce L, et al. Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. N Engl J Med 1995;332: van Dongen JA, Voogd AC, Fentiman IS, Legrand C, Sylvester RJ, Tong D, et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer trial. J Natl Cancer Inst 2000;92: Mirza NQ, Vlastos G, Meric F, Buchholz TA, Esnaola N, Singletary SE, et al. Predictors of locoregional recurrence among patients with earlystage breast cancer treated with breast-conserving therapy. Ann Surg Oncol 2002;9: van den Broek N, van der Sangen MJ, van de Poll-Franse LV, van Beek MW, Nieuwenhuijzen GA, Voogd AC. Margin status and the risk of local recurrence after breast-conserving treatment of lobular breast cancer. Breast Cancer Res Treat 2007;105: Ikeda T, Akiyama F, Hiraoka M, Inaji H, Ohuchi N, Takatsuka Y, et al. Surgical margin status as a cause of local failure after breast conserving therapy. Breast Cancer 1999;6: Luini A, Rososchansky J, Gatti G, Zurrida S, Caldarella P, Viale G, et al. The surgical margin status after breast-conserving surgery: discussion of an open issue. Breast Cancer Res Treat 2009;113: Fredriksson I, Liljegren G, Palm-Sjövall M, Arnesson LG, Emdin SO, Fornander T, et al. Risk factors for local recurrence after breast-conserving surgery. Br J Surg 2003;90: Kurtz JM, Amalric R, Brandone H, Ayme Y, Spitalier JM. Contralateral breast cancer and other second malignancies in patients treated by breast-conserving therapy with radiation. Int J Radiat Oncol Biol Phys 1988;15: Katz A, Strom EA, Buchholz TA, Thames HD, Smith CD, Jhingran A, et al. Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: implications for postoperative irradiation. J Clin Oncol 2000;18: Kurtz JM, Jacquemier J, Amalric R, Brandone H, Ayme Y, Hans D, et al. Why are local recurrences after breast-conserving therapy more frequent in younger patients? J Clin Oncol 1990;8: Müller A, von Fournier D, Kaufmann M, Otto HF, Abel U. Whole breast irradiation and boost irradiation in breast-conserving therapy based on morphologic findings. Breast Dis 1989;2: Cowen D, Jacquemier J, Houvenaeghel G, Viens P, Puig B, Bardou VJ, et al. Local and distant recurrence after conservative management of very low-risk breast cancer are dependent events: a 10-year follow-up. Int J Radiat Oncol Biol Phys 1998;41: Leopold KA, Recht A, Schnitt SJ, Connolly JL, Rose MA, Silver B, et al. Results of conservative surgery and radiation therapy for multiple synchronous cancers of one breast. Int J Radiat Oncol Biol Phys 1989;16: Kurtz JM, Jacquemier J, Amalric R, Brandone H, Ayme Y, Hans D, et al. Breast-conserving therapy for macroscopically multiple cancers. Ann Surg 1990;212: Calle R, Vilcoq JR, Zafrani B, Vielh P, Fourquet A. Local control and survival of breast cancer treated by limited surgery followed by irradiation. Int J Radiat Oncol Biol Phys 1986;12: Stotter AT, McNeese MD, Ames FC, Oswald MJ, Ellerbroek NA. Predicting the rate and extent of locoregional failure after breast conservation therapy for early breast cancer. Cancer 1989;64: Clark RM, McCulloch PB, Levine MN, Lipa M, Wilkinson RH, Mahoney LJ, et al. Randomized clinical trial to assess the effectiveness of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer. J Natl Cancer Inst 1992;84: Straus K, Lichter A, Lippman M, Danforth D, Swain S, Cowan K, et al. Results of the National Cancer Institute early breast cancer trial. J Natl Cancer Inst Monogr 1992;(11): Veronesi U, Banfi A, Salvadori B, Luini A, Saccozzi R, Zucali R, et al. Breast conservation is the treatment of choice in small breast cancer: long-term results of a randomized trial. Eur J Cancer 1990;26: Vicini FA, Kestin LL, Goldstein NS, Baglan KL, Pettinga JE, Martinez AA. Relationship between excision volume, margin status, and tumor size with the development of local recurrence in patients with ductal carcinoma-in-situ treated with breast-conserving therapy. J Surg Oncol 2001;76: Taghian A, Mohiuddin M, Jagsi R, Goldberg S, Ceilley E, Powell S. Current perceptions regarding surgical margin status after breast-conserving therapy: results of a survey. Ann Surg 2005;241: Houssami N, Macaskill P, Marinovich ML, Dixon JM, Irwig L, Brennan ME, et al. Meta-analysis of the impact of surgical margins on local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy. Eur J Cancer 2010;46: Fukamachi K, Ishida T, Usami S, Takeda M, Watanabe M, Sasano H, et al. Total-circumference intraoperative frozen section analysis reduces margin-positive rate in breast-conservation surgery. Jpn J Clin Oncol 2010;40: Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 1989;63: Swenson KK, Decher L, Haselow R, Farrell JB, Sperduto PW. Prognostic factors after conservative surgery and radiation therapy for early stage breast cancer. Am J Clin Oncol 1998;21: Peduzzi P, Concato J, Feinstein AR, Holford TR. Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates. J Clin Epidemiol 1995;48:

Repeating Conservative Surgery after Ipsilateral Breast Tumor Reappearance: Criteria for Selecting the Best Candidates

Repeating Conservative Surgery after Ipsilateral Breast Tumor Reappearance: Criteria for Selecting the Best Candidates Ann Surg Oncol (2012) 19:3771 3776 DOI 10.1245/s10434-012-2404-5 ORIGINAL ARTICLE BREAST ONCOLOGY Repeating Conservative Surgery after Ipsilateral Breast Tumor Reappearance: Criteria for Selecting the

More information

Comparison of survival outcomes between modified radical mastectomy and breast conserving surgery in early breast cancer patients

Comparison of survival outcomes between modified radical mastectomy and breast conserving surgery in early breast cancer patients http://dx.doi.org/10.7180/kmj.2016.31.1.19 KMJ Original Article Comparison of survival outcomes between modified radical mastectomy and breast conserving surgery in early breast cancer patients Yoon Seok

More information

Oncologic safety of breast-conserving surgery in breast cancer patients under the age of 35

Oncologic safety of breast-conserving surgery in breast cancer patients under the age of 35 Korean Journal of Clinical Oncology 217;13:32-38 https://doi.org/1.14216/kjco.174 pissn 1738-882 eissn 2288-484 Original Article Oncologic safety of breast-conserving surgery in breast cancer patients

More information

Clinicopathological Factors Affecting Distant Metastasis Following Loco-Regional Recurrence of breast cancer. Cheol Min Kang 2018/04/05

Clinicopathological Factors Affecting Distant Metastasis Following Loco-Regional Recurrence of breast cancer. Cheol Min Kang 2018/04/05 Abstract No.: ABS-0075 Clinicopathological Factors Affecting Distant Metastasis Following Loco-Regional Recurrence of breast cancer 2018/04/05 Cheol Min Kang Department of surgery, University of Ulsan

More information

CONSERVATIVE therapy in the management of

CONSERVATIVE therapy in the management of Vol. 332 No. 14 BREAST CONSERVATION VERSUS MASTECTOMY IN STAGE I AND II BREAST CANCER 7 TEN-YEAR RESULTS OF A COMPARISON OF CONSERVATION WITH MASTECTOMY IN THE TREATMENT OF STAGE I AND II BREAST CANCER

More information

Breast Cancer. Most common cancer among women in the US. 2nd leading cause of death in women. Mortality rates though have declined

Breast Cancer. Most common cancer among women in the US. 2nd leading cause of death in women. Mortality rates though have declined Breast Cancer Most common cancer among women in the US 2nd leading cause of death in women Mortality rates though have declined 1 in 8 women will develop breast cancer Breast Cancer Breast cancer increases

More information

Breast Cancer. Saima Saeed MD

Breast Cancer. Saima Saeed MD Breast Cancer Saima Saeed MD Breast Cancer Most common cancer among women in the US 2nd leading cause of death in women 1 in 8 women will develop breast cancer Incidence/mortality rates have declined Breast

More information

Tilburg University. Published in: Breast Cancer Research and Treatment. Publication date: Link to publication

Tilburg University. Published in: Breast Cancer Research and Treatment. Publication date: Link to publication Tilburg University Margin status and the risk of local recurrence after breast-conserving treatment of lobular breast cancer van den Broek, N.; van der Sangen, M.J.C.; van de Poll-Franse, L.V.; van Beek,

More information

Classifying Local Disease Recurrences after Breast Conservation Therapy Based on Location and Histology

Classifying Local Disease Recurrences after Breast Conservation Therapy Based on Location and Histology 2059 Classifying Local Disease Recurrences after Breast Conservation Therapy Based on Location and Histology New Primary Tumors Have More Favorable Outcomes than True Local Disease Recurrences Eugene Huang,

More information

The New England Journal of Medicine

The New England Journal of Medicine The New England Journal of Medicine Copyright 22 by the Massachusetts Medical Society VOLUME 347 O CTOBER 17, 22 NUMBER 16 TWENTY-YEAR FOLLOW-UP OF A RANDOMIZED STUDY COMPARING BREAST-CONSERVING SURGERY

More information

Implications of Progesterone Receptor Status for the Biology and Prognosis of Breast Cancers

Implications of Progesterone Receptor Status for the Biology and Prognosis of Breast Cancers 日大医誌 75 (1): 10 15 (2016) 10 Original Article Implications of Progesterone Receptor Status for the Biology and Prognosis of Breast Cancers Naotaka Uchida 1), Yasuki Matsui 1), Takeshi Notsu 1) and Manabu

More information

Breast Cancer? Breast cancer is the most common. What s New in. Janet s Case

Breast Cancer? Breast cancer is the most common. What s New in. Janet s Case Focus on CME at The University of Calgary What s New in Breast Cancer? Theresa Trotter, MD, FRCPC Breast cancer is the most common malignancy affecting women in Canada, accounting for almost a third of

More information

Recurrence following Treatment of Ductal Carcinoma in Situ with Skin-Sparing Mastectomy and Immediate Breast Reconstruction

Recurrence following Treatment of Ductal Carcinoma in Situ with Skin-Sparing Mastectomy and Immediate Breast Reconstruction Recurrence following Treatment of Ductal Carcinoma in Situ with Skin-Sparing Mastectomy and Immediate Breast Reconstruction Aldona J. Spiegel, M.D., and Charles E. Butler, M.D. Houston, Texas Skin-sparing

More information

Differences in outcome for positive margins in a large cohort of breast cancer patients treated with breast-conserving therapy

Differences in outcome for positive margins in a large cohort of breast cancer patients treated with breast-conserving therapy Acta Oncologica ISSN: 0284-186X (Print) 1651-226X (Online) Journal homepage: http://www.tandfonline.com/loi/ionc20 Differences in outcome for positive margins in a large cohort of breast cancer patients

More information

Intraoperative Ultrasound: Improved Resection Rates in Breast-conserving Surgery

Intraoperative Ultrasound: Improved Resection Rates in Breast-conserving Surgery Intraoperative Ultrasound: Improved Resection Rates in Breast-conserving Surgery CHRISTIAN EICHLER 1, ANNETTE HÜBBEL 2, VERENA ZARGHOONI 1, ANKE THOMAS 3, OLEG GLUZ 4, MARIAM STOFF-KHALILI 1 and MATHIAS

More information

METASTASES OF PATIENTS WITH EARLY STAGES OF BREAST CANCER

METASTASES OF PATIENTS WITH EARLY STAGES OF BREAST CANCER Trakia Journal of Sciences, No 4, pp 7-76, 205 Copyright 205 Trakia University Available online at: http://www.uni-sz.bg ISSN 33-7050 (print) doi:0.5547/tjs.205.04.02 ISSN 33-355 (online) Original Contribution

More information

Index. Surg Oncol Clin N Am 16 (2007) Note: Page numbers of article titles are in boldface type.

Index. Surg Oncol Clin N Am 16 (2007) Note: Page numbers of article titles are in boldface type. Surg Oncol Clin N Am 16 (2007) 465 469 Index Note: Page numbers of article titles are in boldface type. A Adjuvant therapy, preoperative for gastric cancer, staging and, 339 B Breast cancer, metabolic

More information

Siong-Seng Liau, Massimiliano Cariati, David Noble, Charles Wilson, Gordon C Wishart

Siong-Seng Liau, Massimiliano Cariati, David Noble, Charles Wilson, Gordon C Wishart BREAST SURGERY doi 10.1308/003588410X12699663903476 Audit of local recurrence following breast conservation surgery with 5-mm target margin and hypofractionated 40-Gray breast radiotherapy for invasive

More information

Advances in Breast Surgery. Catherine Campo, D.O. Breast Surgeon Meridian Health System April 17, 2015

Advances in Breast Surgery. Catherine Campo, D.O. Breast Surgeon Meridian Health System April 17, 2015 Advances in Breast Surgery Catherine Campo, D.O. Breast Surgeon Meridian Health System April 17, 2015 Objectives Understand the surgical treatment of breast cancer Be able to determine when a lumpectomy

More information

Only Estrogen receptor positive is not enough to predict the prognosis of breast cancer

Only Estrogen receptor positive is not enough to predict the prognosis of breast cancer Young Investigator Award, Global Breast Cancer Conference 2018 Only Estrogen receptor positive is not enough to predict the prognosis of breast cancer ㅑ Running head: Revisiting estrogen positive tumors

More information

Outcomes of patients with inflammatory breast cancer treated by breast-conserving surgery

Outcomes of patients with inflammatory breast cancer treated by breast-conserving surgery Breast Cancer Res Treat (2016) 160:387 391 DOI 10.1007/s10549-016-4017-3 EDITORIAL Outcomes of patients with inflammatory breast cancer treated by breast-conserving surgery Monika Brzezinska 1 Linda J.

More information

Prediction of Postoperative Tumor Size in Breast Cancer Patients by Clinical Assessment, Mammography and Ultrasonography

Prediction of Postoperative Tumor Size in Breast Cancer Patients by Clinical Assessment, Mammography and Ultrasonography Prediction of Postoperative Tumor Size in Breast Cancer Patients by Clinical Assessment, Mammography and Ultrasonography Eyad Fawzi AlSaeed 1 and Mutahir A. Tunio 2* 1 Consultant Radiation Oncology, Chairman

More information

Implications of ACOSOG Z11 for Clinical Practice: Surgical Perspective

Implications of ACOSOG Z11 for Clinical Practice: Surgical Perspective :$;7)#*8'-87*4BCD'E7)F'31$4.$&'G$H'E7)F&'GE'>??ID >?,"'@4,$)4*,#74*8'!74/)$++'74',"$'A.,.)$'7%'()$*+,'!*42$)!7)74*67&'!3 6 August 2011 Implications of ACOSOG Z11 for Clinical

More information

Citation Hong Kong Practitioner, 1996, v. 18 n. 2, p

Citation Hong Kong Practitioner, 1996, v. 18 n. 2, p Title Conservative surgery for breast cancer Author(s) Poon, RTP; Chow, LWC; Au, GKH Citation Hong Kong Practitioner, 1996, v. 18 n. 2, p. 68-72 Issued Date 1996 URL http://hdl.handle.net/722/45367 Rights

More information

Predictors of Surgical Margin Following Breast-Conserving Surgery: A Large Population-Based Cohort Study

Predictors of Surgical Margin Following Breast-Conserving Surgery: A Large Population-Based Cohort Study Ann Surg Oncol (2016) 23:S627 S633 DOI 10.1245/s10434-016-5532-5 ORIGINAL ARTICLE BREAST ONCOLOGY Predictors of Surgical Margin Following Breast-Conserving Surgery: A Large Population-Based Cohort Study

More information

Neoadjuvant Treatment of. of Radiotherapy

Neoadjuvant Treatment of. of Radiotherapy Neoadjuvant Treatment of Breast Cancer: Role of Radiotherapy Neoadjuvant Chemotherapy Many new questions for radiation oncology? lack of path stage to guide indications should treatment response affect

More information

Treatment Results and Prognostic Factors of Early Breast Cancer Treated with a Breast Conserving Operation and Radiotherapy

Treatment Results and Prognostic Factors of Early Breast Cancer Treated with a Breast Conserving Operation and Radiotherapy Treatment Results and Prognostic Factors of Early Breast Cancer Treated with a Breast Conserving Operation and Radiotherapy Kyoung Ju Kim 1, Seung Jae Huh 1, Jung-Hyun Yang 2, Won Park 1, Seok Jin Nam

More information

The Role of a Boost Radiation Dose in Patients with Negative Re-Excision Findings

The Role of a Boost Radiation Dose in Patients with Negative Re-Excision Findings 24 The Open Breast Cancer Journal, 2011, 3, 24-28 Open Access The Role of a Boost Radiation Dose in with Negative Re-Excision Melanie C. Smitt and Kathleen C. Horst * Department of Radiation Oncology,

More information

Real-world outcomes of postmastectomy radiotherapy in breast cancer patients with 1 3 positive lymph nodes: a retrospective study

Real-world outcomes of postmastectomy radiotherapy in breast cancer patients with 1 3 positive lymph nodes: a retrospective study Journal of Radiation Research, 2014, 55, 121 128 doi: 10.1093/jrr/rrt084 Advance Access Publication 20 June 2013 Real-world outcomes of postmastectomy radiotherapy in breast cancer patients with 1 3 positive

More information

Clinical Investigation: Breast Cancer

Clinical Investigation: Breast Cancer International Journal of Radiation Oncology biology physics www.redjournal.org Clinical Investigation: Breast Cancer How Do the ASTRO Consensus Statement Guidelines for the Application of Accelerated Partial

More information

Surgical Therapy: Sentinel Node Biopsy and Breast Conservation

Surgical Therapy: Sentinel Node Biopsy and Breast Conservation Surgical Therapy: Sentinel Node Biopsy and Breast Conservation Stephen B. Edge, MD Professor of Surgery and Oncology Roswell Park Cancer Institute University at Buffalo Dr. Roswell Park: Tradition in Cancer

More information

OUTCOME AND PROGNOSTIC FACTORS IN THE CONSERVATIVE TREATMENT OF BREAST CANCER

OUTCOME AND PROGNOSTIC FACTORS IN THE CONSERVATIVE TREATMENT OF BREAST CANCER SPECIAL ISSUES IN BREAST CANCER OUTCOME AND PROGNOSTIC FACTORS IN THE CONSERVATIVE TREATMENT OF BREAST CANCER http://www.lebanesemedicaljournal.org/articles/57-2/doc12.pdf Elie NASR, Dolly NASR, Fares

More information

Consensus Guideline on Accelerated Partial Breast Irradiation

Consensus Guideline on Accelerated Partial Breast Irradiation Consensus Guideline on Accelerated Partial Breast Irradiation Purpose: To outline the use of accelerated partial breast irradiation (APBI) for the treatment of breast cancer. Associated ASBS Guidelines

More information

ANNEX 1 OBJECTIVES. At the completion of the training period, the fellow should be able to:

ANNEX 1 OBJECTIVES. At the completion of the training period, the fellow should be able to: 1 ANNEX 1 OBJECTIVES At the completion of the training period, the fellow should be able to: 1. Breast Surgery Evaluate and manage common benign and malignant breast conditions. Assess the indications

More information

Position Statement on Management of the Axilla in Patients with Invasive Breast Cancer

Position Statement on Management of the Axilla in Patients with Invasive Breast Cancer - Official Statement - Position Statement on Management of the Axilla in Patients with Invasive Breast Cancer Sentinel lymph node (SLN) biopsy has replaced axillary lymph node dissection (ALND) for the

More information

Treatment results and predictors of local recurrences after breast conserving therapy in early breast carcinoma

Treatment results and predictors of local recurrences after breast conserving therapy in early breast carcinoma Journal of BUON 8: 241-246, 2003 2003 Zerbinis Medical Publications. Printed in Greece ORIGINAL ARTICLE Treatment results and predictors of local recurrences after breast conserving therapy in early breast

More information

Debate Axillary dissection - con. Prof. Dr. Rodica Anghel Institute of Oncology Bucharest

Debate Axillary dissection - con. Prof. Dr. Rodica Anghel Institute of Oncology Bucharest Debate Axillary dissection - con Prof. Dr. Rodica Anghel Institute of Oncology Bucharest Summer School of Oncology, third edition Updated Oncology 2015: State of the Art News & Challenging Topics Bucharest,

More information

Surgery for Breast Cancer

Surgery for Breast Cancer Surgery for Breast Cancer 1750 Mastectomy - Petit 1894 Radical mastectomy Halsted Extended, Super radical mastectomy 1948 Modified radical mastectomy Patey 1950-60 WLE & RT Baclesse, Mustakallio 1981-85

More information

Why Do Axillary Dissection? Nodal Treatment and Survival NSABP B04. Revisiting Axillary Dissection for SN Positive Patients

Why Do Axillary Dissection? Nodal Treatment and Survival NSABP B04. Revisiting Axillary Dissection for SN Positive Patients Memorial Sloan-Kettering Cancer Center 1275 York Avenue, New York, NY 10065 10th International Congress on the Future of Breast Cancer Coronado, CA Why Do Axillary Dissection? 6 August 2011 Implications

More information

Table of contents. Page 2 of 40

Table of contents. Page 2 of 40 Page 1 of 40 Table of contents Introduction... 4 1. Background Information... 6 1a: Referral source for the New Zealand episodes... 6 1b. Invasive and DCIS episodes by referral source... 7 1d. Age of the

More information

National Center of Oncology - Yerevan, Armenia

National Center of Oncology - Yerevan, Armenia - Yerevan, Armenia General Information New breast cancer cases treated per year 450 Breast multidisciplinarity team members 13 Radiologists, surgeons, pathologists, medical oncologists, radiotherapists

More information

Loco-Regional Management After Neoadjuvant Chemotherapy

Loco-Regional Management After Neoadjuvant Chemotherapy 1 Loco-Regional Management After Neoadjuvant Chemotherapy Terry Mamounas, M.D., M.P.H., F.A.C.S. Medical Director, Comprehensive Breast Program UF Health Cancer Center at Orlando Health Professor of Surgery,

More information

Implications of ACOSOG Z11 for Clinical Practice: Surgical Perspective

Implications of ACOSOG Z11 for Clinical Practice: Surgical Perspective Memorial Sloan-Kettering Cancer Center 1275 York Avenue, New York, NY 10065 10th International Congress on the Future of Breast Cancer Coronado, CA 6 August 2011 Implications of ACOSOG Z11 for Clinical

More information

BREAST MRI. Elizabeth A. Rafferty, M.D. Avon Comprehensive Breast Center Massachusetts General Hospital Harvard Medical School

BREAST MRI. Elizabeth A. Rafferty, M.D. Avon Comprehensive Breast Center Massachusetts General Hospital Harvard Medical School BREAST MRI Elizabeth A. Rafferty, M.D. Avon Comprehensive Breast Center Massachusetts General Hospital Harvard Medical School BREAST MRI Any assessment of the breast parenchyma requires the administration

More information

Locoregional treatment Session Oral Abstract Presentation Saulo Brito Silva

Locoregional treatment Session Oral Abstract Presentation Saulo Brito Silva Locoregional treatment Session Oral Abstract Presentation Saulo Brito Silva Background Post-operative radiotherapy (PORT) improves disease free and overall suvivallin selected patients with breast cancer

More information

The Use of the Latissimus dorsi Flap in Breast Reconstruction of Post-Mastectomy Patients: Is Superior to the Use of Expander / Prosthesis?

The Use of the Latissimus dorsi Flap in Breast Reconstruction of Post-Mastectomy Patients: Is Superior to the Use of Expander / Prosthesis? Research Article imedpub Journals http://www.imedpub.com Journal of Aesthetic & Reconstructive Surgery DOI: 10.4172/2472-1905.100014 The Use of the Latissimus dorsi Flap in Breast Reconstruction of Post-Mastectomy

More information

What is Cancer? Petra Ketterl, MD Medical Oncology and Functional Medicine

What is Cancer? Petra Ketterl, MD Medical Oncology and Functional Medicine What is Cancer? Petra Ketterl, MD Medical Oncology and Functional Medicine What is Cancer? Layman s terms: cancer starts when cells grow out of control (in any place in the body) and crowd out normal cells

More information

Journal of Breast Cancer

Journal of Breast Cancer Journal of Breast Cancer ORIGINAL ARTICLE J Breast Cancer 2012 September; 15(3): 329-336 Radiation Treatment in Pathologic N0-N1 Patients Treated with Neoadjuvant Chemotherapy Followed by Surgery for Locally

More information

Breast Cancer Diagnosis, Treatment and Follow-up

Breast Cancer Diagnosis, Treatment and Follow-up Breast Cancer Diagnosis, Treatment and Follow-up What is breast cancer? Each of the body s organs, including the breast, is made up of many types of cells. Normally, healthy cells grow and divide to produce

More information

Sang Min Hong*, Eun Young Kim*, Kwan Ho Lee, Yong Lai Park, Chan Heun Park

Sang Min Hong*, Eun Young Kim*, Kwan Ho Lee, Yong Lai Park, Chan Heun Park ORIGINAL ARTICLE J Breast Dis 2018 June; 6(1): 11-19 JBD Journal of Breast Disease Predictors of Positive or Close Surgical Margins in Breast-Conserving Surgery for Patients with Breast Cancer Sang Min

More information

The Challenge of Individualizing Loco-Regional Treatments for Patients with Localized Breast Cancer

The Challenge of Individualizing Loco-Regional Treatments for Patients with Localized Breast Cancer The Challenge of Individualizing Loco-Regional Treatments for Patients with Localized Breast Cancer Le défi des traitements locorégionaux individualisés pour les patientes présentant un cancer du sein

More information

Journal of Breast Cancer

Journal of Breast Cancer Journal of Breast Cancer ORIGINAL ARTICLE J Breast Cancer 215 June; 18(2): 167-172 Treatment Outcome of Breast Cancer with Pathologically Proven Synchronous Ipsilateral Supraclavicular Lymph Node Metastases

More information

When do you need PET/CT or MRI in early breast cancer?

When do you need PET/CT or MRI in early breast cancer? When do you need PET/CT or MRI in early breast cancer? Elizabeth A. Morris MD FACR Chief, Breast Imaging Service Memorial Sloan-Kettering Cancer Center NY, NY Objectives What is the role of MRI in initial

More information

Loco-Regional Management After Neoadjuvant Chemotherapy

Loco-Regional Management After Neoadjuvant Chemotherapy 1 Loco-Regional Management After Neoadjuvant Chemotherapy Terry Mamounas, M.D., M.P.H., F.A.C.S. Medical Director, Comprehensive Breast Program UF Health Cancer Center at Orlando Health Professor of Surgery,

More information

ARTICLE IN PRESS. doi: /j.ijrobp METAPLASTIC CARCINOMA OF THE BREAST: A RETROSPECTIVE REVIEW

ARTICLE IN PRESS. doi: /j.ijrobp METAPLASTIC CARCINOMA OF THE BREAST: A RETROSPECTIVE REVIEW doi:10.1016/j.ijrobp.2005.08.024 Int. J. Radiation Oncology Biol. Phys., Vol. xx, No. x, pp. xxx, 2005 Copyright 2005 Elsevier Inc. Printed in the USA. All rights reserved 0360-3016/05/$ see front matter

More information

PMRT for N1 breast cancer :CONS. Won Park, M.D., Ph.D Department of Radiation Oncology Samsung Medical Center

PMRT for N1 breast cancer :CONS. Won Park, M.D., Ph.D Department of Radiation Oncology Samsung Medical Center PMRT for N1 breast cancer :CONS Won Park, M.D., Ph.D Department of Radiation Oncology Samsung Medical Center DBCG 82 b & c Overgaard et al Radiot Oncol 2007 1152 pln(+), 8 or more nodes removed Systemic

More information

Long term survival study of de-novo metastatic breast cancers with or without primary tumor resection

Long term survival study of de-novo metastatic breast cancers with or without primary tumor resection Long term survival study of de-novo metastatic breast cancers with or without primary tumor resection Dr. Michael Co Division of Breast Surgery Queen Mary Hospital The University of Hong Kong Conflicts

More information

Barlavento Medical Centre - Portimão, Portugal

Barlavento Medical Centre - Portimão, Portugal - Portimão, Portugal General Information New breast cancer cases treated per year 150 Breast multidisciplinarity team members 9 Radiologists, surgeons, pathologists, medical oncologists, radiotherapists

More information

Case Scenario 1. 2/15/2011 The patient received IMRT 45 Gy at 1.8 Gy per fraction for 25 fractions.

Case Scenario 1. 2/15/2011 The patient received IMRT 45 Gy at 1.8 Gy per fraction for 25 fractions. Case Scenario 1 1/3/11 A 57 year old white female presents for her annual mammogram and is found to have a suspicious area of calcification, spread out over at least 4 centimeters. She is scheduled to

More information

BreastScreen Aotearoa Annual Report 2015

BreastScreen Aotearoa Annual Report 2015 BreastScreen Aotearoa Annual Report 2015 EARLY AND LOCALLY ADVANCED BREAST CANCER PATIENTS DIAGNOSED IN NEW ZEALAND IN 2015 Prepared for Ministry of Health, New Zealand Version 1.0 Date November 2017 Prepared

More information

Clinical outcomes after sentinel lymph node biopsy in clinically node-negative breast cancer patients

Clinical outcomes after sentinel lymph node biopsy in clinically node-negative breast cancer patients Original Article Radiat Oncol J 4;():-7 http://dx.doi.org/.857/roj.4... pissn 4-9 eissn 4-56 Clinical outcomes after sentinel lymph node biopsy in clinically node-negative breast cancer patients Hee Ji

More information

Angela Gilliam, MD University of Colorado Surgical Grand Rounds November 3, 2008

Angela Gilliam, MD University of Colorado Surgical Grand Rounds November 3, 2008 Angela Gilliam, MD University of Colorado Surgical Grand Rounds November 3, 2008 Breast Cancer Most common cancer in American women 180,000 new cases per year Second most common cause of cancer death 44,000

More information

Initial Margin Status for Invasive Ductal Carcinoma of the Breast and Subsequent Identification of Carcinoma in Reexcision Specimens

Initial Margin Status for Invasive Ductal Carcinoma of the Breast and Subsequent Identification of Carcinoma in Reexcision Specimens Initial Margin Status for Invasive Ductal Carcinoma of the Breast and Subsequent Identification of Carcinoma in Reexcision Specimens Silvia Skripenova, MD; Lester J. Layfield, MD N Context. Margin status

More information

Resection Margins in Breast Conserving Surgery. Alberto Costa, MD Canton Ticino Breast Unit Lugano, Switzerland

Resection Margins in Breast Conserving Surgery. Alberto Costa, MD Canton Ticino Breast Unit Lugano, Switzerland Resection Margins in Breast Conserving Surgery Alberto Costa, MD Canton Ticino Breast Unit Lugano, Switzerland Breast Conserving Surgery 1 Probably one of the most important innovation in cancer surgery

More information

Ductal Carcinoma in Situ (DCIS)

Ductal Carcinoma in Situ (DCIS) Diagnosis and Treatment of Patients with Primary and Metastatic Breast Cancer Ductal Carcinoma in Situ (DCIS) Ductal Carcinoma in Situ DCIS Versions 2002 2017: Audretsch / Blohmer / Brunnert / Budach /

More information

Impact of Disturbed Wound Healing after Surgery on the Prognosis of Marjolin s Ulcer

Impact of Disturbed Wound Healing after Surgery on the Prognosis of Marjolin s Ulcer Impact of Disturbed Wound Healing after Surgery on the Prognosis of Marjolin s Ulcer Jae Yeon Choi, Yong Chan Bae, Su Bong Nam, Seong Hwan Bae Department of Plastic and Reconstructive Surgery, Pusan National

More information

Radiation and DCIS. The 16 th Annual Conference on A Multidisciplinary Approach to Comprehensive Breast Care and Imaging

Radiation and DCIS. The 16 th Annual Conference on A Multidisciplinary Approach to Comprehensive Breast Care and Imaging Radiation and DCIS The 16 th Annual Conference on A Multidisciplinary Approach to Comprehensive Breast Care and Imaging Einsley-Marie Janowski, MD, PhD Assistant Professor Department of Radiation Oncology

More information

BREAST CANCER SURGERY. Dr. John H. Donohue

BREAST CANCER SURGERY. Dr. John H. Donohue Dr. John H. Donohue HISTORY References to breast surgery in ancient Egypt (ca 3000 BCE) Mastectomy described in numerous medieval texts Petit formulated organized approach in 18 th Century Improvements

More information

Long-term Follow-up for Patients with Papillary Thyroid Carcinoma Treated as Benign Nodules

Long-term Follow-up for Patients with Papillary Thyroid Carcinoma Treated as Benign Nodules Long-term Follow-up for Patients with Papillary Thyroid Carcinoma Treated as Benign Nodules YASUHIRO ITO, TAKUYA HIGASHIYAMA, YUUKI TAKAMURA, AKIHIRO MIYA, KAORU KOBAYASHI, FUMIO MATSUZUKA, KANJI KUMA

More information

Should Breast Density Influence Patient Selection for Breast-Conserving Surgery?

Should Breast Density Influence Patient Selection for Breast-Conserving Surgery? Ann Surg Oncol (2013) 20:600 606 DOI 10.1245/s10434-012-2604-z ORIGINAL ARTICLE BREAST ONCOLOGY Should Breast Density Influence Patient Selection for Breast-Conserving Surgery? Nimmi S. Kapoor, MD 1, Anne

More information

Mamma Centrum / Zelený Pruh - Prague, Czech Republic

Mamma Centrum / Zelený Pruh - Prague, Czech Republic - Prague, Czech Republic General Information New breast cancer cases treated per year 490 Breast multidisciplinarity team members 29 Radiologists, surgeons, pathologists, medical oncologists, radiotherapists

More information

Advances in Localized Breast Cancer

Advances in Localized Breast Cancer Advances in Localized Breast Cancer Melissa Camp, MD, MPH and Fariba Asrari, MD June 18, 2018 Moderated by Elissa Bantug 1 Advances in Surgery for Breast Cancer Melissa Camp, MD June 18, 2018 2 Historical

More information

16/09/2015. ACOSOG Z011 changing practice. Presentation outline. Nodal mets #1 prognostic tool. Less surgery no change in oncologic outcomes

16/09/2015. ACOSOG Z011 changing practice. Presentation outline. Nodal mets #1 prognostic tool. Less surgery no change in oncologic outcomes ACOSOG Z011 changing practice The end of axillary US/FNA? Preoperative staging of the axilla in the era of Z011 Adena S Scheer MD MSc FRCSC Surgical Oncologist, St. Michael s Hospital Assistant Professor,

More information

Surgeons Experience In Breast Conserving Surgery: Does It Influence Surgical Margin?

Surgeons Experience In Breast Conserving Surgery: Does It Influence Surgical Margin? Original Research Article Surgeons Experience In Breast Conserving Surgery: Does It Influence Surgical Margin? Shahrun Niza AS 1 ( ), Ussof Eskaandar MH 2, Nani Harlina ML 1, Razrim R 1, Rohaizak M 1 1

More information

Stage-to-stage Comparison of Neoadjuvant Chemotherapy Versus Adjuvant Chemotherapy in Pathological Lymph Node Positive Breast Cancer Patients

Stage-to-stage Comparison of Neoadjuvant Chemotherapy Versus Adjuvant Chemotherapy in Pathological Lymph Node Positive Breast Cancer Patients Original Articles Jpn J Clin Oncol 2012;42(11)995 1001 doi:10.1093/jjco/hys130 Advance Access Publication 21 August 2012 Stage-to-stage Comparison of Neoadjuvant Chemotherapy Versus Adjuvant Chemotherapy

More information

Radiation Field Design and Patterns of Locoregional Recurrence Following Definitive Radiotherapy for Breast Cancer

Radiation Field Design and Patterns of Locoregional Recurrence Following Definitive Radiotherapy for Breast Cancer International Journal of Radiation Oncology biology physics www.redjournal.org Clinical Investigation: Breast Cancer Radiation Field Design and Patterns of Locoregional Recurrence Following Definitive

More information

University of Groningen. Local treatment in young breast cancer patients Joppe, Enje Jacoba

University of Groningen. Local treatment in young breast cancer patients Joppe, Enje Jacoba University of Groningen Local treatment in young breast cancer patients Joppe, Enje Jacoba IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from

More information

RADIOTHERAPY IN BREAST CANCER :

RADIOTHERAPY IN BREAST CANCER : RADIOTHERAPY IN BREAST CANCER : PAST, PRESENT, FUTURE Dr Jyotirup Goswami Consultant Radiation Oncologist Narayana Cancer Institute Narayana Superspecialty Hospital Breast cancer is the classic paradigm

More information

Locoregional Outcomes in Clinical Stage IIB Breast Cancer After Neoadjuvant Therapy and Mastectomy With or Without Radiation

Locoregional Outcomes in Clinical Stage IIB Breast Cancer After Neoadjuvant Therapy and Mastectomy With or Without Radiation Locoregional Outcomes in Clinical Stage IIB Breast Cancer After Neoadjuvant Therapy and Mastectomy With or Without Radiation Dayssy A. Diaz, MD, Judith Hurley, MD, Isildinha Reis, PhD, Cristiane Takita,

More information

Acute and late adverse effects of breast cancer radiation: Two hypo-fractionation protocols

Acute and late adverse effects of breast cancer radiation: Two hypo-fractionation protocols ORIGINAL ARTICLES Acute and late adverse effects of breast cancer radiation: Two hypo-fractionation protocols Mohamed Abdelhamed Aboziada 1, Samir Shehata 2 1 Department of Radiation Oncology, South Egypt

More information

Imaging Surveillance in Women with a History of Treated Breast Cancer. Wei Tse Yang, M.D.

Imaging Surveillance in Women with a History of Treated Breast Cancer. Wei Tse Yang, M.D. Imaging Surveillance in Women with a History of Treated Breast Cancer Wei Tse Yang, M.D. Breast Cancer 1. Extent 2. Response 3. Recurrence Surveillance Breast Cancer 1. Extent 2. Response Surveillance

More information

Diagnosis and staging of breast cancer and multidisciplinary team working

Diagnosis and staging of breast cancer and multidisciplinary team working 1 Diagnosis and staging of breast cancer and multidisciplinary team working Common symptoms and signs Over 90% of breast cancers (BCs) are local or regional when first detected. At least 60% of patients

More information

Clinica Medellin - Medellin, Colombia

Clinica Medellin - Medellin, Colombia - Medellin, Colombia General Information New breast cancer cases treated per year 150 Breast multidisciplinarity team members 12 Radiologists, surgeons, pathologists, medical oncologists, radiotherapists

More information

Accuracy of Specimen Radiography in Assessing Complete Local Excision with Breast-Conservation Surgery

Accuracy of Specimen Radiography in Assessing Complete Local Excision with Breast-Conservation Surgery RESEARCH ARTICLE Editorial Process: Submission:09/22/2017 Acceptance:01/21/2018 Accuracy of Specimen Radiography in Assessing Complete Local Excision with Breast-Conservation Surgery Saira Naz, Imrana

More information

Classification System

Classification System Classification System A graduate of the Breast Oncology training program should be able to care for all aspects of disease and/or provide comprehensive management. When referring to a discipline of training

More information

Surgical Considerations in Breast Cancer treated with Neoadjuvant Therapy

Surgical Considerations in Breast Cancer treated with Neoadjuvant Therapy Surgical Considerations in Breast Cancer treated with Neoadjuvant Therapy Rebecca Warburton MD Department of Surgery, University of British Columbia Mount Saint Joseph Hospital, Providence Health Care

More information

Groote Schuur Academic Hospital - Cape Town, South Africa

Groote Schuur Academic Hospital - Cape Town, South Africa - Cape Town, South Africa General Information New breast cancer cases treated per year 400 Breast multidisciplinarity team members 7 Radiologists, surgeons, pathologists, medical oncologists, radiotherapists

More information

University Clinical Center Banja Luka, Breast Center - Banja Luka, Bosnia and Herzegovina

University Clinical Center Banja Luka, Breast Center - Banja Luka, Bosnia and Herzegovina - Banja Luka, Bosnia and Herzegovina General Information New breast cancer cases treated per year 245 Breast multidisciplinarity team members 23 Radiologists, surgeons, pathologists, medical oncologists,

More information

Radiotherapy Management of Breast Cancer Treated with Neoadjuvant Chemotherapy. Julia White MD Professor, Radiation Oncology

Radiotherapy Management of Breast Cancer Treated with Neoadjuvant Chemotherapy. Julia White MD Professor, Radiation Oncology Radiotherapy Management of Breast Cancer Treated with Neoadjuvant Chemotherapy Julia White MD Professor, Radiation Oncology Agenda Efficacy of radiotherapy in the management of breast cancer in the Adjuvant

More information

PET/CT in breast cancer staging

PET/CT in breast cancer staging PET/CT in breast cancer staging Anni Morsing Consultant, PhD, DMSc Rigshospitalet 1 18F- FDG PET/CT for breastcancer staging Where is the clinical impact? To which women should 18F- FDG PET/CT be offered?

More information

BREAST MRI. Elizabeth A. Rafferty, M.D. Avon Comprehensive Breast Center Massachusetts General Hospital Harvard Medical School

BREAST MRI. Elizabeth A. Rafferty, M.D. Avon Comprehensive Breast Center Massachusetts General Hospital Harvard Medical School BREAST MRI Elizabeth A. Rafferty, M.D. Avon Comprehensive Breast Center Massachusetts General Hospital Harvard Medical School BREAST MRI Any assessment of the breast parenchyma requires the administration

More information

San Donato Hospital - Azienda USL TOSCANA SUDEST Arezzo - Arezzo, Italy

San Donato Hospital - Azienda USL TOSCANA SUDEST Arezzo - Arezzo, Italy San Donato Hospital - Azienda USL TOSCANA SUDEST Arezzo - Arezzo, Italy General Information New breast cancer cases treated per year 255 Breast multidisciplinarity team members 18 Radiologists, surgeons,

More information

Retrospective analysis to determine the use of tissue genomic analysis to predict the risk of recurrence in early stage invasive breast cancer.

Retrospective analysis to determine the use of tissue genomic analysis to predict the risk of recurrence in early stage invasive breast cancer. Retrospective analysis to determine the use of tissue genomic analysis to predict the risk of recurrence in early stage invasive breast cancer. Goal of the study: 1.To assess whether patients at Truman

More information

HOSPITAL MODELO - LA CORUÑA, Spain

HOSPITAL MODELO - LA CORUÑA, Spain - LA CORUÑA, Spain General Information New breast cancer cases treated per year 150 Breast multidisciplinarity team members 8 Radiologists, surgeons, pathologists, medical oncologists, radiotherapists

More information

ARROCase - April 2017

ARROCase - April 2017 ARROCase - April 2017 Radiation Indications in the setting of Neoadjuvant chemotherapy for Breast Cancer Lauren Colbert, MD, MSCR Faculty Mentor: Benjamin Smith, MD UT MD Anderson Cancer Center 37 year

More information

Breast Clinica de la Mama and Italian Hospital - La Plata, Argentina

Breast Clinica de la Mama and Italian Hospital - La Plata, Argentina - La Plata, Argentina General Information New breast cancer cases treated per year 382 Breast multidisciplinarity team members 18 Radiologists, surgeons, pathologists, medical oncologists, radiotherapists

More information

Civic Hospital of Sanremo ASL 1 Imperiese - Sanremo, Italy

Civic Hospital of Sanremo ASL 1 Imperiese - Sanremo, Italy - Sanremo, Italy General Information New breast cancer cases treated per year 188 Breast multidisciplinarity team members 10 Radiologists, surgeons, pathologists, medical oncologists, radiotherapists and

More information

Results of the ACOSOG Z0011 Trial

Results of the ACOSOG Z0011 Trial DCIS and Early Breast Cancer Symposium JUNE 15-17 2012 CAPPADOCIA Results of the ACOSOG Z0011 Trial Kelly K. Hunt, M.D. Professor of Surgery Axillary Node Dissection Staging, Regional control, Survival

More information

Dyson Center for Cancer Care - Poughkeepsie, New York, United States of America

Dyson Center for Cancer Care - Poughkeepsie, New York, United States of America - Poughkeepsie, New York, United States of America General Information New breast cancer cases treated per year 323 Breast multidisciplinarity team members 14 Radiologists, surgeons, pathologists, medical

More information

Radiotherapy Implications of ACOSOG Z-11 for Clinical Practice. Julia White, MD Professor of Radiation Oncology Medical College of Wisconsin

Radiotherapy Implications of ACOSOG Z-11 for Clinical Practice. Julia White, MD Professor of Radiation Oncology Medical College of Wisconsin 1 Radiotherapy Implications of ACOSOG Z-11 for Clinical Practice Julia White, MD Professor of Radiation Oncology Medical College of Wisconsin Disclosures: none Agenda 1. ACOSOG Z-11: Another perspective

More information